Diabetic peripheral neuropathy is notably widespread, affecting up to 62 percent of people with diabetes mellitus in India. Diabetic peripheral neuropathy primarily affects the hands and lower limbs.

If type 2 diabetes is left untreated, it can lead to a number of complications, including nerve damage. The most commonly ...

(4) Denervated bands of Schwann cells. Multifocal diabetic neuropathy. Cross section of a paraffin-embedded superficial peroneal nerve specimen from a patient with a subacute progressive ...

More severe peripheral neuropathy is associated with elevated dry eye disease risk in patients with type 2 diabetes. Among patients with type 2 diabetes (T2D), greater dry eye disease (DED) risk is ...

Background: Identifying distinct mechanisms and biomarkers for painful diabetic peripheral neuropathy (DPN) is required for advancing the treatment of this major global unmet clinical need. We ...

Peripheral neuropathy encompasses a variety of conditions marked by damage or lesions to peripheral nerves, resulting in symptoms such as pain, itch, and sensory disturbances. Diseases such as ...

Type 2 diabetes can go undetected for many years because the symptoms do not usually make you feel unwell; when they do ...

Type 2 diabetes can have a harmful impact on the body if blood sugar levels are left unchecked. Diabetic neuropathy can be ...

Diabetic neuropathy is the most common neuropathy in industrialized countries, and it is associated with a wide range of clinical manifestations. The vast majority of patients with clinical ...

If these symptoms sound familiar, and you are a patient with type 1 or type 2 diabetes, you may be experiencing symptoms associated with diabetic peripheral neuropathy. Diabetic neuropathy is nerve ...

Mumbai: Alkem Laboratories Ltd. has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, Inc to develop, manufacture and commercialise the drug candidate “SON-080” for the ...

The agreement focuses on developing, manufacturing, and commercializing ‘SON-080’ in India for treating diabetic peripheral neuropathy. Alkem will conduct clinical trials of ‘SON-080’ in I ...